Research Topic

Biological Delivery: Bridging Fundamental Research with the Clinic and Industry

About this Research Topic

Delivery of pharmaceuticals, nanomaterials, imaging agents, and biomolecular manipulation tools is critical for many biotechnology and bioengineering fields, ranging from protein therapeutics to genome editing. Biological delivery is challenging, and is often the bottleneck in many cases, because biological systems (e.g., cells, brain, and tumors) present many natural transport barriers against objects deemed 'foreign'. In the past several decades numerous advanced delivery technologies have been reported to improve delivery performance in biological systems. Most recently, in the global fight against the COVID-19 pandemic, the use of nanoparticles-based delivery systems has been crucial to the success of some of the best vaccines.

Translation of advanced delivery technologies to the clinic and industry has proven to be extremely challenging. Success stories like the above-mentioned delivery systems for COVID-19 vaccines remain very limited. This Research Topic aims to provide a platform for bridging fundamental research in biological delivery with the clinic and industry. New advances, reviews and opinions that can facilitate dialogues and translation will be published in this Research Topic.

This Research Topic publishes high quality articles on the broad topic of biological delivery, with a focus on bridging fundamental research with the clinic and industry. The submitted manuscripts could be in the form of Original Research articles, Reviews, Perspectives and Opinions. Specific themes include but are not limited to:
· Understanding the complex transport behaviors of exogenous entities in biological systems;
· Toxicology and immunology of nanomedicine;
· Delivery of proteins and RNA therapeutics and genome-editing tools;
· Scalable production of delivery systems;
· Overcoming delivery barriers of tumors, brain and the eye;
· Clinical studies of biological delivery technologies;
· Precision nanomedicine;
· Historical accounts of translation of delivery technologies to the clinic/industry;
· Delivery for theranostics;
· Delivery for regenerative medicine;
· Opinions on hurdles of translation.

Gang Ruan is a co-founder and equity holder of Core Quantum Technologies, a company developing nanomaterials-based products for biomedical analysis. He holds patents transferred to the company.


Keywords: Protein therapeutics, Genome editing, Translation, Immune engineering, Nanomedicine


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Delivery of pharmaceuticals, nanomaterials, imaging agents, and biomolecular manipulation tools is critical for many biotechnology and bioengineering fields, ranging from protein therapeutics to genome editing. Biological delivery is challenging, and is often the bottleneck in many cases, because biological systems (e.g., cells, brain, and tumors) present many natural transport barriers against objects deemed 'foreign'. In the past several decades numerous advanced delivery technologies have been reported to improve delivery performance in biological systems. Most recently, in the global fight against the COVID-19 pandemic, the use of nanoparticles-based delivery systems has been crucial to the success of some of the best vaccines.

Translation of advanced delivery technologies to the clinic and industry has proven to be extremely challenging. Success stories like the above-mentioned delivery systems for COVID-19 vaccines remain very limited. This Research Topic aims to provide a platform for bridging fundamental research in biological delivery with the clinic and industry. New advances, reviews and opinions that can facilitate dialogues and translation will be published in this Research Topic.

This Research Topic publishes high quality articles on the broad topic of biological delivery, with a focus on bridging fundamental research with the clinic and industry. The submitted manuscripts could be in the form of Original Research articles, Reviews, Perspectives and Opinions. Specific themes include but are not limited to:
· Understanding the complex transport behaviors of exogenous entities in biological systems;
· Toxicology and immunology of nanomedicine;
· Delivery of proteins and RNA therapeutics and genome-editing tools;
· Scalable production of delivery systems;
· Overcoming delivery barriers of tumors, brain and the eye;
· Clinical studies of biological delivery technologies;
· Precision nanomedicine;
· Historical accounts of translation of delivery technologies to the clinic/industry;
· Delivery for theranostics;
· Delivery for regenerative medicine;
· Opinions on hurdles of translation.

Gang Ruan is a co-founder and equity holder of Core Quantum Technologies, a company developing nanomaterials-based products for biomedical analysis. He holds patents transferred to the company.


Keywords: Protein therapeutics, Genome editing, Translation, Immune engineering, Nanomedicine


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
31 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
31 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..